Social and clinical predictors of short- and long-term readmission after a severe exacerbation of copd.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 08 10 2019
accepted: 02 02 2020
entrez: 28 2 2020
pubmed: 28 2 2020
medline: 10 5 2020
Statut: epublish

Résumé

The aim of this study was to evaluate the predictive ability of multiple social, and clinical factors for readmission after a severe acute exacerbation of COPD (AECOPD) during various time periods. We performed a prospective cohort study in which recruited patients with AECOPD. We systematically collected numerous clinical (symptoms, pulmonary function, comorbidities, and treatment) and social (financial situation, housing situation, family support, caregiver overload, ability to perform activities, and risk of social exclusion) variables using several questionnaires and indices. The patients were followed closely for one year and readmissions at 30, 60, and 365 days were analysed. 253 patients were included, aged 68.9±9.8years, FEV1 = 42.1%±14.2%, and a Charlson's index = 1.8±0.9. Of these patients, 20.2%, 39.6%, and 63.7% were readmitted within the first 30, 90, and 365 days after discharge, respectively. In the multivariate model applied, the variables that were independently associated with readmission over all three periods of the analysis were dependence to perform basic activities of daily living (BADLs) (odds ratio [OR] = 2.10-4.10) and a history of two or more admissions within the previous year (OR = 2.78-3.78). At 90 days, a history of bacterial isolates in a previous sputum culture (OR = 2.39) and at 365 days, a high grade of dyspnoea (OR = 2.51) and obesity (OR = 2.38) were also identified as predictors of hospital readmission. The patients' limitation to perform BADLs and their history of admissions for AECOPD were the best predictive variables for the likelihood of readmission when adjusted for many other social and clinical variables, regardless of the time period considered for such prediction.

Identifiants

pubmed: 32106226
doi: 10.1371/journal.pone.0229257
pii: PONE-D-19-28169
pmc: PMC7046279
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0229257

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Int J Chron Obstruct Pulmon Dis. 2017 Mar 24;12:989-995
pubmed: 28392683
Int J Chron Obstruct Pulmon Dis. 2007;2(3):241-51
pubmed: 18229562
Thorax. 2003 Feb;58(2):100-5
pubmed: 12554887
Eur Respir J. 2016 Jan;47(1):113-21
pubmed: 26493806
BMC Pulm Med. 2011 Nov 04;11:49
pubmed: 22054636
Curr Opin Pulm Med. 2016 Mar;22(2):106-12
pubmed: 26814142
Chest. 2017 Jan;151(1):68-77
pubmed: 27568229
Int J Cardiol. 2019 Mar 1;278:167-172
pubmed: 30587417
Int J Chron Obstruct Pulmon Dis. 2017 Oct 05;12:2891-2908
pubmed: 29062228
BMJ. 1988 Oct 8;297(6653):897-9
pubmed: 3140969
J Hum Nutr Diet. 2013 Jul;26 Suppl 1:16-22
pubmed: 23656492
Soc Work Health Care. 2015;54(3):234-51
pubmed: 25760490
Curr Opin Pulm Med. 2018 Mar;24(2):138-146
pubmed: 29210750
Health Serv Res. 2019 Apr;54(2):324-326
pubmed: 30848490
Aging Clin Exp Res. 2018 May;30(5):489-497
pubmed: 28770477
J Gen Intern Med. 2017 Jan;32(1):71-80
pubmed: 27848189
Curr Med Res Opin. 2011 May;27(5):981-6
pubmed: 21385019
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
Am J Respir Crit Care Med. 2018 Apr 15;197(8):1009-1017
pubmed: 29206052
Ann Am Thorac Soc. 2019 Feb;16(2):161-170
pubmed: 30707066
Health Qual Life Outcomes. 2012 Oct 30;10:130
pubmed: 23110491
Int J Cardiol. 2018 Mar 1;254:240-241
pubmed: 29407098
Int J Chron Obstruct Pulmon Dis. 2017 Sep 08;12:2687-2693
pubmed: 28932112
Can Respir J. 2008 Oct;15(7):361-4
pubmed: 18949105
Ann Am Thorac Soc. 2018 Jul;15(7):837-845
pubmed: 29611719
Int J Chron Obstruct Pulmon Dis. 2016 Jun 07;11:1199-206
pubmed: 27354778
Ther Adv Respir Dis. 2017 Oct;11(10):383-392
pubmed: 28849736
Ann Am Thorac Soc. 2018 Jul;15(7):801-803
pubmed: 29957037
Arch Bronconeumol. 2015 Oct;51(10):483-9
pubmed: 25447590
Chest. 2016 Oct;150(4):916-926
pubmed: 27167208
Int J Surg. 2014 Dec;12(12):1500-24
pubmed: 25046751
Thorax. 2017 Aug;72(8):686-693
pubmed: 28235886
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
Int J Nurs Stud. 2012 Apr;49(4):490-504
pubmed: 22078211
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
JBI Database System Rev Implement Rep. 2017 Feb;15(2):454-485
pubmed: 28178023

Auteurs

Sara Fernández-García (S)

Department of Pneumonology, University Hospital Complex of Vigo, Pontevedra, Spain.
Neumo Vigo I +i. Institute of Health Research Galicia Sur (IISGS, Instituto de Investigación Sanitaria Galicia Sur), Vigo, Pontevedra, Spain.

Cristina Represas-Represas (C)

Department of Pneumonology, University Hospital Complex of Vigo, Pontevedra, Spain.
Neumo Vigo I +i. Institute of Health Research Galicia Sur (IISGS, Instituto de Investigación Sanitaria Galicia Sur), Vigo, Pontevedra, Spain.

Alberto Ruano-Raviña (A)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP, Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública), Madrid, Spain.

Cecilia Mouronte-Roibás (C)

Department of Pneumonology, University Hospital Complex of Vigo, Pontevedra, Spain.
Neumo Vigo I +i. Institute of Health Research Galicia Sur (IISGS, Instituto de Investigación Sanitaria Galicia Sur), Vigo, Pontevedra, Spain.

Maribel Botana-Rial (M)

Department of Pneumonology, University Hospital Complex of Vigo, Pontevedra, Spain.
Neumo Vigo I +i. Institute of Health Research Galicia Sur (IISGS, Instituto de Investigación Sanitaria Galicia Sur), Vigo, Pontevedra, Spain.

Cristina Ramos-Hernández (C)

Department of Pneumonology, University Hospital Complex of Vigo, Pontevedra, Spain.
Neumo Vigo I +i. Institute of Health Research Galicia Sur (IISGS, Instituto de Investigación Sanitaria Galicia Sur), Vigo, Pontevedra, Spain.

Alberto Fernández-Villar (A)

Department of Pneumonology, University Hospital Complex of Vigo, Pontevedra, Spain.
Neumo Vigo I +i. Institute of Health Research Galicia Sur (IISGS, Instituto de Investigación Sanitaria Galicia Sur), Vigo, Pontevedra, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH